1	Tyrosine	Tyrosine	_	_	_	_	_	_	_
2	kinase	kinase	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	cAMP-dependent	camp-dependent	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	kinase	kinase	_	_	_	_	_	_	_
7	activities	activity	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	CD40-activated	cd40-activated	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	B	B	_	_	_	_	_	_	_
12	lymphocytes	lymphocyte	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	vitro	vitro	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	lymphocytes	lymphocyte	_	_	_	_	_	_	_
7	undergo	undergo	_	_	_	_	_	_	_
8	long-term	long-term	_	_	_	_	_	_	_
9	proliferation	proliferation	_	_	_	_	_	_	_
10	when	when	_	_	_	_	_	_	_
11	activated	activate	_	_	_	_	_	_	_
12	through	through	_	_	_	_	_	_	_
13	CD40	CD40	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	protein	protein	_	_	_	_	_	_	_
17	expressed	express	_	_	_	_	_	_	_
18	on	on	_	_	_	_	_	_	_
19	their	their	_	_	_	_	_	_	_
20	cell	cell	_	_	_	_	_	_	_
21	surface	surface	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	nature	nature	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	CD40-dependent	cd40-dependent	_	_	_	_	_	_	_
5	signals	signal	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	proliferating	proliferate	_	_	_	_	_	_	_
8	fresh	fresh	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
11	virus-negative	virus-negative	_	_	_	_	_	_	_
12	B	B	_	_	_	_	_	_	_
13	lymphocytes	lymphocyte	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	currently	currently	_	_	_	_	_	_	_
16	unknown	unknown	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	CD40-dependent	cd40-dependent	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	culture	culture	_	_	_	_	_	_	_
10	system	system	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	used	use	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	examine	examine	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	role	role	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	different	different	_	_	_	_	_	_	_
19	signal	signal	_	_	_	_	_	_	_
20	transduction	transduction	_	_	_	_	_	_	_
21	elements	element	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Protein	protein	_	_	_	_	_	_	_
2	kinase	kinase	_	_	_	_	_	_	_
3	C	C	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	PKC	PKC	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	depletion	depletion	_	_	_	_	_	_	_
8	generated	generate	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	long-term	long-term	_	_	_	_	_	_	_
12	phorbol	phorbol	_	_	_	_	_	_	_
13	12	12	_	_	_	_	_	_	_
14	myristate	myristate	_	_	_	_	_	_	_
15	13-acetate	13-acetate	_	_	_	_	_	_	_
16	treatment	treatment	_	_	_	_	_	_	_
17	had	have	_	_	_	_	_	_	_
18	weak	weak	_	_	_	_	_	_	_
19	effects	effect	_	_	_	_	_	_	_
20	on	on	_	_	_	_	_	_	_
21	proliferation	proliferation	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Rather	rather	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	tyrosine	tyrosine	_	_	_	_	_	_	_
4	phosphorylation	phosphorylation	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	shown	show	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	be	be	_	_	_	_	_	_	_
9	directly	directly	_	_	_	_	_	_	_
10	involved	involve	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	mediating	mediate	_	_	_	_	_	_	_
13	CD40-dependent	cd40-dependent	_	_	_	_	_	_	_
14	signals	signal	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	use	use	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	tyrosine	tyrosine	_	_	_	_	_	_	_
7	kinase	kinase	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	PTK)-specific	ptk)-specific	_	_	_	_	_	_	_
10	inhibitor	inhibitor	_	_	_	_	_	_	_
11	herbimycin	herbimycin	_	_	_	_	_	_	_
12	A	a	_	_	_	_	_	_	_
13	dramatically	dramatically	_	_	_	_	_	_	_
14	decreased	decrease	_	_	_	_	_	_	_
15	cellular	cellular	_	_	_	_	_	_	_
16	proliferation	proliferation	_	_	_	_	_	_	_
17	without	without	_	_	_	_	_	_	_
18	altering	alter	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	activity	activity	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	human	human	_	_	_	_	_	_	_
24	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
25	virus-1	virus-1	_	_	_	_	_	_	_
26	long	long	_	_	_	_	_	_	_
27	terminal	terminal	_	_	_	_	_	_	_
28	repeat	repeat	_	_	_	_	_	_	_
29	(	(	_	_	_	_	_	_	_
30	HIV-1	HIV-1	_	_	_	_	_	_	_
31	LTR	LTR	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	a	a	_	_	_	_	_	_	_
35	promoter	promoter	_	_	_	_	_	_	_
36	largely	largely	_	_	_	_	_	_	_
37	dependent	dependent	_	_	_	_	_	_	_
38	on	on	_	_	_	_	_	_	_
39	the	the	_	_	_	_	_	_	_
40	binding	binding	_	_	_	_	_	_	_
41	of	of	_	_	_	_	_	_	_
42	nuclear	nuclear	_	_	_	_	_	_	_
43	factor	factor	_	_	_	_	_	_	_
44	kappa	kappa	_	_	_	_	_	_	_
45	B	B	_	_	_	_	_	_	_
46	(	(	_	_	_	_	_	_	_
47	NF-	nf-	_	_	_	_	_	_	_
48	kappa	kappa	_	_	_	_	_	_	_
49	B	B	_	_	_	_	_	_	_
50	)	)	_	_	_	_	_	_	_
51	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	cAMP-dependent	camp-dependent	_	_	_	_	_	_	_
6	protein	protein	_	_	_	_	_	_	_
7	kinase	kinase	_	_	_	_	_	_	_
8	specific	specific	_	_	_	_	_	_	_
9	inhibitor	inhibitor	_	_	_	_	_	_	_
10	H-89	h-89	_	_	_	_	_	_	_
11	totally	totally	_	_	_	_	_	_	_
12	inhibited	inhibit	_	_	_	_	_	_	_
13	HIV-1	HIV-1	_	_	_	_	_	_	_
14	LTR	LTR	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	at	at	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	concentration	concentration	_	_	_	_	_	_	_
19	as	as	_	_	_	_	_	_	_
20	low	low	_	_	_	_	_	_	_
21	as	as	_	_	_	_	_	_	_
22	100	100	_	_	_	_	_	_	_
23	nM	nm	_	_	_	_	_	_	_
24	without	without	_	_	_	_	_	_	_
25	affecting	affect	_	_	_	_	_	_	_
26	cellular	cellular	_	_	_	_	_	_	_
27	proliferation	proliferation	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
2	mobility	mobility	_	_	_	_	_	_	_
3	shift	shift	_	_	_	_	_	_	_
4	assay	assay	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	EMSA	EMSA	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	supershift	supershift	_	_	_	_	_	_	_
10	assay	assay	_	_	_	_	_	_	_
11	using	use	_	_	_	_	_	_	_
12	an	an	_	_	_	_	_	_	_
13	NF-kappa	NF-kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	binding	binding	_	_	_	_	_	_	_
16	sequence	sequence	_	_	_	_	_	_	_
17	from	from	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	kappa	kappa	_	_	_	_	_	_	_
20	light	light	_	_	_	_	_	_	_
21	chain	chain	_	_	_	_	_	_	_
22	as	as	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	probe	probe	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	revealed	reveal	_	_	_	_	_	_	_
27	that	that	_	_	_	_	_	_	_
28	both	both	_	_	_	_	_	_	_
29	p65	p65	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	RelA	RelA	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	c-Rel	c-rel	_	_	_	_	_	_	_
35	were	be	_	_	_	_	_	_	_
36	present	present	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	CD40-stimulated	cd40-stimulated	_	_	_	_	_	_	_
39	B	B	_	_	_	_	_	_	_
40	cells	cell	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	While	while	_	_	_	_	_	_	_
2	PKC	PKC	_	_	_	_	_	_	_
3	depletion	depletion	_	_	_	_	_	_	_
4	did	do	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	alter	alter	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	level	level	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	treatment	treatment	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	lymphocytes	lymphocyte	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	H-89	H-89	_	_	_	_	_	_	_
18	or	or	_	_	_	_	_	_	_
19	herbimycin	herbimycin	_	_	_	_	_	_	_
20	A	a	_	_	_	_	_	_	_
21	provoked	provoke	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	decrease	decrease	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	NF-kappa	NF-kappa	_	_	_	_	_	_	_
27	B	B	_	_	_	_	_	_	_
28	level	level	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	observations	observation	_	_	_	_	_	_	_
3	establish	establish	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	importance	importance	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	different	different	_	_	_	_	_	_	_
8	signal	signal	_	_	_	_	_	_	_
9	transducing	transducing	_	_	_	_	_	_	_
10	pathways	pathway	_	_	_	_	_	_	_
11	leading	lead	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	CD40	CD40	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	lymphocytes	lymphocyte	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

